Increase of phosphodiesters during neuroleptic treatment of schizophrenics: A longitudinal 31P-magnetic resonance spectroscopic study

Biological Psychiatry

Volumn 45, Issue 9, 1999, Pages 1221-1225

  Volz, H P ^a   Rossger, G ^a   Riehemann, S ^a   Hubner, G ^a   Maurer, I ^a   Wenda, B ^a   Rzanny, R ^a   Kaiser, W A ^a   Sauer, H ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

31P magnetic resonance spectroscopy; Neuroleptics; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; PHOSPHOLIPASE A2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FRONTAL LOBE; HIGH ENERGY PHOSPHATE; HUMAN; LONGITUDINAL STUDY; MALE; PHOSPHOLIPID METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0033134929     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00366-7     Document Type: Article

References (20)

1. M Albers H Meurer F Marki J Klotz Phospholipase A2 activity in serum of neuroleptic-naive psychiatric inpatients Pharmacopsychiatry 26 1993 94 98
2. de Beer R (1994): Lectures notes, ”Quantitative in vivo NMR”. University of Technology Delft. accessible at http://dutnsic.tn.tudelft.nl:8080/c59_to_html/c59.html.
3. P.A Bottomly The trouble with spectroscopy papers Radiology 181 1991 344 350
4. R.M.C Dawson Enzymatic pathways of phospholipid metabolism in the nervous system J Eichberg Phospholipids in nervous tissue 1985 Wiley New York 45 78
5. W.F Gattaz M Köllisch T Thuren J.A Virtanen P.K.J Kinnunen Increased plasma phospholipase-A2 activity in schizophrenic patients Reduction after neuroleptic therapy Biol Psychiatry 22 1987 421 426
6. W.F Gattaz CvK Hübner T.T Nevalainen P.K.J Kinnunen Increased serum phospholipase A2 activity in schizophrenia A replication study Biol Psychiatry 28 1990 495 501
7. W Janiec M Pytlik T Pierkarska The influence of psychotropic drugs on the phosphodiesterase activity in the rat brain Pol J Pharmacol Pharm 32 1980 297 303
8. 13C enriched metabolites from cell suspensions incubated in deuterated media Magn Reson Med 36 1996 359 365
9. R.C Oldfield The assessment and analysis of handedness The Edinburgh Inventory Neuropsychol 9 1971 97 133
10. R.R Ordige A Connelly J.A Lohman Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy J Magn Reson Imag 66 1986 283 294
11. J.W Pettegrew M.S Keshawan K Panchalingam S Strychor D.B Kaplan M.G Tretta Alterations in brain high-energy phosphate and membrane metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy Arch Gen Psychiatry 48 1991 563 568
12. 31P nuclear magnetic resonance spectroscopy Neurology 35 1985 781 788
13. S Riehemann H.P Volz C Gaser H Sauer Phosphorous NMR in schizophrenia—The influence of different evaluation methods on spectral interpretation NeuroImage 7 1998 S621
14. M Rudin A Sauter In vivo phosphorus-31 NMR: Potential and limitations M Rudin Vol 28 of NMR-Basic Principles and Progress 1992 Springer Berlin 161 188
15. H.I Trzeciak W Kalacinski A Malecki A Kokot Effects of neuroleptics on phospholipase A2 activity in the brain of rats Eur Arch Psychiatry Clin Neurosci 245 1995 179 182
16. J.A Stanley P.C Williamson D.J Drost T.J Carr J Rylett A Malla An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy Arch Gen Psychiatry 52 1995 399 406
17. 31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique—preliminary findings Biol Psychiatry 41 1997 644 648
18. 31P-magneto-resonance spectroscopic study Psychiatry Res Neuroimag 76 1997 123 129
19. 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics—a study including 50 patients and 36 controls Biol Psychiatry 44 1998 399 404
20. 31P magnetic resonance spectroscopy studies in schizophrenia Prostaglandins Leukot Essent Fatty Acids 55 1996 115 118